TrialBlood advances2025

Patient-reported improvements in paroxysmal nocturnal hemoglobinuria treated with iptacopan from 2 phase 3 studies.

Antonio M Risitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.